Inspired by our previous efforts on the modifications of diarylpyrimidines as HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTI) and reported crystallography study, novel diarylnicotinamide derivatives were designed with a "triazole tail" occupying the entrance channel in the NNRTI binding pocket of the reverse transcriptase to afford additional interactions. The newly designed compounds were then synthesized and evaluated for their anti-HIV activities in MT-4 cells. All the compounds showed excellent to good activity against wild-type HIV-1 strain with EC of 0.02-1.77 μM. Evaluations of selected compounds against more drug-resistant strains showed these compounds had advantage of inhibiting E138K mutant virus which is a key drug-resistant mutant to the new generation of NNRTIs. Among this series, propionitrile (3b2, EC = 0.020 μM, EC = 0.015 μM, CC = 40.15 μM), pyrrolidin-1-ylmethanone (3b8, EC = 0.020 μM, EC = 0.014 μM, CC = 58.09 μM) and morpholinomethanone (3b9, EC = 0.020 μM, EC = 0.027 μM, CC = 180.90 μM) derivatives are the three most promising compounds which are equally potent to the marketed drug Etravirine against E138K mutant strain but with much lower cytotoxicity. Furthermore, detailed SAR, inhibitory activity against RT and docking study of the representative compounds are also discussed.
Five new lindenane sesquiterpene dimers ( 1- 5), named shizukaols K-O, and eight known sesquiterpene dimers were isolated from the roots of Chloranthus fortunei. The structures of 1- 5 were elucidated using spectroscopic data, mainly 1D NMR, 2D NMR, and mass spectra.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.